Skip to main navigation
Skip to search
Skip to main content
University of Toyama Home
日本語
English
Home
Profiles
Research units
Projects
Research output
Datasets
Prizes
Activities
Courses
Search by expertise, name or affiliation
Therapeutic potential of Keishi-bukuryo-gan on diabetic nephropathy
Takako Nakagawa
*
*
Corresponding author for this work
Joint Institute of Teacher Education
Research output
:
Contribution to journal
›
Article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Therapeutic potential of Keishi-bukuryo-gan on diabetic nephropathy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Therapeutic Potential
100%
Keishibukuryogan
100%
Diabetic Nephropathy
100%
Advanced Glycation End Products
42%
Oxidative Stress
28%
Diabetic Patients
14%
Clinical Manifestations
14%
Antioxidant
14%
Inhibitory Effect
14%
Morphological Changes
14%
Kidney
14%
Oral Administration
14%
Diabetic
14%
Streptozotocin
14%
Metabolic Pathway
14%
Angiotensin-converting Enzyme Inhibitor (ACEi)
14%
Lipid Peroxidation Inhibition
14%
Urinary Protein Excretion
14%
Vascular System
14%
Persistent Hyperglycemia
14%
System Disorders
14%
Polyol Pathway
14%
Subtotal Nephrectomy
14%
Butylated Hydroxytoluene
14%
Diabetic Kidney Damage
14%
Chinese Traditional Medicine
14%
Aminoguanidine
14%
Glycation Reaction
14%
Hand Disorders
14%
Diabetic Glomerulosclerosis
14%
Diabetic Nephropathy Rats
14%
Captopril
14%
Pharmacology, Toxicology and Pharmaceutical Science
Keishi Bukuryo Gan
100%
Diabetic Nephropathy
100%
Advanced Glycation End Product
42%
Disease
28%
Diabetes Mellitus
14%
Antioxidant
14%
Hyperglycemia
14%
Kidney Injury
14%
Streptozotocin
14%
Deterioration
14%
Traditional Chinese Medicine
14%
Dipeptidyl Carboxypeptidase Inhibitor
14%
Butylcresol
14%
Aminoguanidine
14%
Captopril
14%
Polyol
14%